Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch(Johns Hopkins University), Aaron A.R. Tobian(Johns Hopkins University), Jeffrey A. Bailey(John Brown University), Lewis Pollack(Oldham Council), Paul G. Auwaerter(Office of Infectious Diseases), Brenda J. Grossman(Washington University in St. Louis), David Sullivan(Johns Hopkins University), Wayne T. Nicholson(Mayo Clinic), Shmuel Shoham(Office of Infectious Diseases), Bruce S. Sachais(New York Blood Center), Jeffrey L. Winters(Mayo Clinic), Amy Wesolowski(Johns Hopkins University), Steven L. Spitalnik(Columbia University Irving Medical Center), Hua Shan(Stanford Medicine), Andrew Pekosz(Johns Hopkins University), Camille van Buskirk(Mayo Clinic), Jeffrey P. Henderson(Washington University in St. Louis), Nigel Paneth, Beth H. Shaz(Duke University), Arturo Casadevall(Johns Hopkins University), Eric A. Gehrie(Institute for Transfusion Medicine), Michael J. Joyner(WinnMed), David L. Thomas(University College London), Eldad A. Hod(Columbia University), Louis M. Katz, Liise‐anne Pirofski(Montefiore Medical Center), Bryan Lau(Johns Hopkins University)
Cited by 863
Related Papers
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
|Nature Reviews Microbiology|2015|1.3k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k
Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
|Annals of Internal Medicine|2012|1.1k
The Natural History of Hepatitis C Virus Infection
|JAMA|2000|1.1k